Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001628280-25-017079
Filing Date
2025-04-08
Accepted
2025-04-08 16:34:04
Documents
16
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A blfs-20241231.htm   iXBRL 10-K/A 727607
2 EX-31.3 blfs-20241231xexx313.htm EX-31.3 3847
3 EX-31.4 blfs-20241231xexx314.htm EX-31.4 3841
  Complete submission text file 0001628280-25-017079.txt   1247333

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blfs-20241231.xsd EX-101.SCH 1938
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blfs-20241231_lab.xml EX-101.LAB 132367
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blfs-20241231_pre.xml EX-101.PRE 71174
18 EXTRACTED XBRL INSTANCE DOCUMENT blfs-20241231_htm.xml XML 4798
Mailing Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021
Business Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 4254011400
BIOLIFE SOLUTIONS INC (Filer) CIK: 0000834365 (see all company filings)

EIN.: 943076866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36362 | Film No.: 25822401
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)